# TEAM (Trial on Efficacy and Quality of Life Among Asthmatic Patient With Montelukast)

> **NCT03096327** · PHASE4 · COMPLETED · sponsor: **PharmEvo Pvt Ltd** · enrollment: 180 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Montelukast
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03096327
- **Lead sponsor:** PharmEvo Pvt Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-01
- **Primary completion:** 2017-12-30
- **Final completion:** 2018-05-30
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2018-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03096327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03096327, "TEAM (Trial on Efficacy and Quality of Life Among Asthmatic Patient With Montelukast)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03096327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*